Systemic sclerosis (SSc) is a multisystem autoimmune rheumatic disease that results in substantial morbidity and significant mortality. Indeed, it is the autoimmune rheumatic disease with the highest case-specific mortality and it occurs as a result of organ-based complications. Historically, renal manifestations were a very important cause of death, but recent series show that most patients dying from SSc do so as a result of cardiopulmonary complications including, pulmonary hypertension, lung fibrosis, and myocardial involvement [1]. In many cases, there is co-occurrence of these different manifestations, and this may account for the particular severity of SSc. Although there are a range of ways in which the kidneys can be affected in SSc, the most significant renal manifestation is the scleroderma renal crisis (SRC), and this was historically a major cause of scleroderma-associated death. Other causes of renal pathology should however always be considered in SSc [2].
CITATION STYLE
Denton, C. P., & Steen, V. (2012). Scleroderma renal crisis. In Scleroderma: From Pathogenesis to Comprehensive Management (pp. 361–371). Springer US. https://doi.org/10.1007/978-1-4419-5774-0_29
Mendeley helps you to discover research relevant for your work.